ArticleImmunity, inflammation and disease2026
Clinical Analysis of Neonatal Influenza in the Neonatal Intensive Care Unit: A Retrospective Study.
Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Analysis of Neonatal Influenza in the Neonatal Intensive Care Unit: A Retrospective Study.Immunity, inflammation and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo describe the clinical characteristics, treatment, and outcomes of neonatal influenza.
methodsRetrospectively analyzed clinical data on 26 neonates who were diagnosed with neonatal influenza by positive influenza nasopharyngeal swab antigen tests, and admitted to the neonatal intensive care unit of Sichuan Province Chengdu Integrated TCM & Western Medicine Hospital in China, between January 2022 to December 2023.
resultsTwenty-six neonates were admitted, 25 with influenza A, whereas 1 co-infected influenza A and B. Nine patients had close contact with family members showing respiratory symptoms prior to hospitalization. Common symptoms included fever (53.85%), nasal congestion (46.15%), cough, neonatal jaundice, and loss of appetite. The most frequent laboratory abnormalities were elevated CK-MB (92.3%), lactic acid (80.77%), prominent lymphocytosis in both count and percentage, elevated monocyte percentage and AST. All patients treated with oseltamivir and recovered.
conclusionIn this single-year study, influenza A was the predominant type identified. The clinical symptoms are non-specific, and main symptom is fever 14/26 (53.85%). Treatment with oseltamivir is safe and had favorable outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.